ellie semaglutide Friday briefing: Are appetite-suppressing drugs really a fast track to weight loss? | World news How GLP-1 therapies like semaglutide

Quick Answer: GLP-1 receptor agonists are not licensed or supported by clinical evidence for rheumatoid arthritis treatment in the UK, and microdosing remains experimental without established safety or efficacy data

Both drugs appear to dampen the mesolimbic dopaminergic reward pathway, which is why many patients describe reduced cravings for alcohol, sweets, and ultra-processed food within the first month

This blend is also relevant in studies focused on skin health, particularly in improving firmness, elasticity, and overall appearance

All IV services carry some risk (like bruising, irritation, or allergic reaction)

Additionally, DSIP does not extend sleep beyond the normal duration nor does it impair the normal sleep architecture

Any GLP-1 medicine should be used only under a doctors guidance